ISRCTN ISRCTN21175670
DOI https://doi.org/10.1186/ISRCTN21175670
Protocol serial number HTA 02/37/03
Sponsor Department of Health (UK)
Funder NIHR Health Technology Assessment Programme - HTA (UK)
Submission date
06/06/2005
Registration date
09/06/2005
Last edited
21/07/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Elizabeth Andrea Nelson
Scientific

School of Healthcare
Baines Wing
University of Leeds
Leeds
LS2 9JT
United Kingdom

Phone +44 (0)113 3431373
Email E.A.Nelson@leeds.ac.uk

Study information

Primary study designInterventional
Study designRandomised controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific title
Study acronymVenUS III
Study objectivesLow dose ultrasound will accelerate the healing of 'hard to heal' venous leg ulcers used in addition to compression bandaging
Ethics approval(s)Added 21 August 2008: Favourable ethics review provided by York Research Ethics Committee (UK) on 04/02/2005 (Ref 05/Q1108/3).
Health condition(s) or problem(s) studiedVenous ulcers
InterventionLow dose ultrasound administered weekly for 12 weeks, for between 5 and 10 minutes using in conjunction with compression therapy versus compression therapy alone.
Intervention typeOther
Primary outcome measure(s)

Time to complete healing of all ulcers.

Key secondary outcome measure(s)

1. Proportion of patients with all ulcers healed at 24 weeks
2. Costs of healing ulcers
3. Health related quality of life
4. 12 month recurrence rate

Completion date30/10/2009

Eligibility

Participant type(s)Patient
Age groupAdult
SexAll
Target sample size at registration336
Key inclusion criteriaPeople with venous ulcers treated in community or hospital out-patients with venous ulcers defined as hard to heal based on their being larger than 5 cm^2 or of greater than 6 months duration (or both).
Able and willing to give informed written consent.
Key exclusion criteriaActive infection in the ulcer, presence of shrapnel or joint replacements near ulcerated area; allergy to ultrasound transmission gel.
Date of first enrolment01/05/2005
Date of final enrolment30/10/2009

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centre

School of Healthcare
Leeds
LS2 9JT
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/05/2009 Yes No
Results article results 01/03/2011 Yes No
Results article results 08/03/2011 Yes No
Protocol article protocol 01/01/2006 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes
Study website Study website 11/11/2025 11/11/2025 No Yes